Scientific Advisor, Advent Life Sciences
Fraser is a neuropharmacologist with almost 30 years of drug discovery and early development experience across a range of therapeutic areas, including neurodegeneration, psychiatry, inflammation, gastrointestinal and dermatology. He has a wide C-suite experience in multiple biotech startups and held leadership roles at Shire, AstraZeneca, Merck , Calcico Therapeutics, Chronos Therapeutics & Pandeia Therapeutics.
Fraser holds an MBA from Alliance Manchester Business School, a PhD in neuropharmacology from the University of London and a BSc in immunology and pharmacology from the University of Strathclyde.